scholarly journals Patients Tested at a Laboratory for Hereditary Cancer Syndromes Show an Overlap for Multiple Syndromes in Their Personal and Familial Cancer Histories

Oncology ◽  
2015 ◽  
Vol 89 (5) ◽  
pp. 288-293 ◽  
Author(s):  
Jennifer Saam ◽  
Christopher Arnell ◽  
Aaron Theisen ◽  
Kelsey Moyes ◽  
Ingrid Marino ◽  
...  
2016 ◽  
pp. 276-290
Author(s):  
Henry T. Lynch ◽  
Carrie L. Snyder ◽  
Jane F. Lynch

Thanks to the veritably logarithmic advances in the molecular genetics of many emerging hereditary cancer syndromes, genetic counselling has become of paramount importance. It is a key element of the emerging concepts for patient education and management, which have become the clinical bedrock for diagnosis and management of hereditary cancer. Genetic counsellors have become proficient in the understanding of the complexities of molecular genetics in relation to hereditary cancer syndromes, demonstrating their ability both to supplement and replace the customary physician’s role in this overall process. We have used colorectal cancer, in particular Lynch syndrome, as a clinical genetic model based on the authors’ experience with diagnosis, DNA testing, and counselling of thousands of families for over four decades. Undoubtedly, the surface of the proverbial iceberg has barely been grazed in regard to the developments for the genetic counseling discipline.


2014 ◽  
Vol 32 (30_suppl) ◽  
pp. 216-216
Author(s):  
Lucia Fontes-Borts ◽  
Howard Safran ◽  
Kimberly Perez

216 Background: Of patients diagnosed with colorectal cancer, 5-10% of all cancers are associated with hereditary cancer syndromes. Since hereditary gastrointestinal cancer syndromes convey a markedly increased risk for developing cancer, identification of affected families is important. Studies have found that clinicians are unlikely to adequately or routinely collect family history information on their patients. This study assessed the implementation of a validated three-generation family history intake tool by an advanced practiced nurse practitioner (APNP) and the impact on clinical practice at a mid-size academic affiliated Medical Oncology practice. Methods: From September 2013 to January 2014, 100 patients with the diagnosis of colorectal cancer were assessed after a clinic session with a physician by an APNP. The APNP utilized a validated 3 - generation family history tool. Information regarding age, sex, education, annual income, family ethnicity, diet, exercise and previous genetic testing was also collected. Data collected was then analyzed to assess risk of hereditary syndrome. A chart review of the patients was performed to analyze microsatellite instability testing and prior genetic counseling referrals. Results: Of the 100 screened, 93 patients were evaluable. There were 52 males: 39 female participants with a median age of 60.71 years (range 28-90). The implementation of FCHT was associated with an increase in identification of individuals at risk; 16 (17.2%) patients reported a diagnosis of CRC at age less than 50. The rate of referrals for genetic evaluation tripled after the implementation of the FCHT (6.5% to 16.3%). Of the 17 referred, five had been referred prior to implementation of the FCHT. Conclusions: Institution of a separate session with an APNP to assess family history resulted in a 3-fold increase in rates of detection of patients with high risk for hereditary cancer syndromes associated with colorectal cancer.This study demonstrates that APNP’s are well positioned to promote preventative health by engaging in family history intake and genetic assessment referral.


Author(s):  
Carrie L. Snyder ◽  
Heather Hampel ◽  
Henry T. Lynch

Thanks to the veritably logarithmic advances in the molecular genetics of many emerging hereditary cancer syndromes, genetic counselling has become of paramount importance. It is a key element of the emerging concepts for patient education and management, which have become the clinical bedrock for diagnosis and management of hereditary cancer. Genetic counsellors have become proficient in the understanding of the complexities of molecular genetics in relation to hereditary cancer syndromes, demonstrating their ability both to supplement and replace the customary physician’s role in this overall process. We have used colorectal cancer, in particular Lynch syndrome, as a clinical genetic model based on the authors’ experience with diagnosis, DNA testing, and counselling of thousands of families for over four decades. Undoubtedly, the surface of the proverbial iceberg has barely been grazed in regard to the developments for the genetic counseling discipline.


2021 ◽  
Vol 41 (3) ◽  
pp. 218-228
Author(s):  
Rosario Ferrer‐Avargues ◽  
María Isabel Castillejo ◽  
Estela Dámaso ◽  
Virginia Díez‐Obrero ◽  
Noemí Garrigos ◽  
...  

2021 ◽  
pp. 1709-1718
Author(s):  
Kathleen F. Mittendorf ◽  
Sarah Knerr ◽  
Tia L. Kauffman ◽  
Nangel M. Lindberg ◽  
Katherine P. Anderson ◽  
...  

2016 ◽  
Vol 43 (1) ◽  
pp. 134-145 ◽  
Author(s):  
Farzana L. Walcott ◽  
Jigar Patel ◽  
Ronald Lubet ◽  
Luz Rodriguez ◽  
Kathleen A. Calzone

Sign in / Sign up

Export Citation Format

Share Document